Authors:
Ridolfo, AL
Gervasoni, C
Bini, T
Galli, M
Citation: Al. Ridolfo et al., Body habitus alterations in HIV-Infected women treated with combined antiretroviral therapy, AIDS PAT CA, 14(11), 2000, pp. 595-601
Authors:
Antinori, S
Ridolfo, AL
Gianelli, E
Piazza, M
Gervasoni, C
Monforte, AD
Citation: S. Antinori et al., The role of lumbar puncture in the management of elevated intracranial pressure in patients with AIDS-associated cryptococcal meningitis, CLIN INF D, 31(5), 2000, pp. 1309-1310
Authors:
Ridolfo, AL
Gervasoni, C
Antinori, S
Pizzuto, M
Santambrogio, S
Trabattoni, D
Clerici, M
Galli, M
Citation: Al. Ridolfo et al., Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum, J INFECTION, 40(2), 2000, pp. 199-202
Authors:
Antinori, S
Esposito, R
Ridolfo, AL
Santambrogio, S
Sollima, S
Moroni, M
Citation: S. Antinori et al., Highly active antiretroviral therapy as an effective treatment for azole-refractory candidiasis, INF DIS C P, 8(8), 1999, pp. 403-407
Authors:
Errante, D
Gabarre, J
Ridolfo, AL
Rossi, G
Nosari, AM
Gisselbrecht, C
Kerneis, Y
Mazzetti, E
Vaccher, E
Talamini, R
Carbone, A
Tirelli, U
Citation: D. Errante et al., Hodgkin's disease in 35 patients with HIV infection: An experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combinationwith antiretroviral therapy and primary use of G-CSF, ANN ONCOL, 10(2), 1999, pp. 189-195
Authors:
Gervasoni, C
Ridolfo, AL
Trifiro, G
Santambrogio, S
Norbiato, G
Musicco, M
Clerici, M
Galli, M
Moroni, M
Citation: C. Gervasoni et al., Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy, AIDS, 13(4), 1999, pp. 465-471
Authors:
Balotta, C
Bagnarelli, P
Corvasce, S
Mazzucchelli, R
Colombo, MC
Papagno, L
Santambrogio, S
Ridolfo, AL
Violin, M
Berlusconi, A
Velleca, R
Facchi, G
Moroni, M
Clementi, M
Galli, M
Citation: C. Balotta et al., Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis, J INFEC DIS, 180(2), 1999, pp. 285-289